Executive team
Senior business strategist; former Sales & Marketing Director; M.Sc. in Neuroscience.
Psychiatry resident with hands-on clinical experience, M.Sc. in Neuroscience from Oxford.
World expert on PTSD and has uncovered the potential of secondary prevention in PTSD (Ex- Sheba director of Psychiatry, Ex-chair director of European Neuropsychopharmacology association, former president, and chairman of the Expert Platform on Mental Health).
Professor of Psychiatry (Ex-head of Rambam hospital Psychiatry), Co-Founder and Head of Medical and Scientific Affairs at ICAR Collective, Former Head of Mental Health of the IDF.
A board built
for approval.
Nine advisors across business strategy, regulatory development and clinical psychiatry — assembled specifically for the path from Phase 2 to market.
Business and Strategy Advisory
Over 25 years of clinical and management experience in the biopharmaceutical industry. Serves on the boards of noted institutes and has led multiple biotech companies to IPO.
20+ years biotech executive experience as CEO, COO, of private and public companies.
Strategic life sciences executive with over 15 years of experience in drug development and multidisciplinary program management.
Regulatory & Development
Former FDA medical officer and former U.S. Army psychiatric officer.
Executive-level clinical development experience, former CMO of multiple bio-pharma companies.
Deep expertise in medical-device development and design for manufacture.
Additional Clinical Experience
Former Chief of Psychiatry, Sha'ar Menashe; Head of Psychiatry, MedTrix.
Former Chair of Psychiatry at Tel Aviv Medical Center (Ichilov) and Head of its Neuropsychiatry Clinic.
Director of the Emory Healthcare Veterans Program, Paul A. Janssen Chair in Neuropsychopharmacology, PTSD research specialized.
We choose who
we build with.
Every partnership is a decision, not an acceptance. We work only with institutions that share the conviction behind this company — that preventing psychiatric injury is a responsibility, not an opportunity.
Accelerators, clinical networks and national programmes that want to change the world, and are prepared to do the hard work it takes.
